Glucagonoma syndrome. Report of two cases and literature review
- 1 June 1977
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Dermatology
- Vol. 113 (6) , 749-754
- https://doi.org/10.1001/archderm.113.6.749
Abstract
The glucagonoma syndrome is characterized by dermatitis, stomatitis, elevated serum glucagon levels, abnormal glucose tolerance, weight loss and anemia, all in association with a glucagon-secreting .alpha. cell tumor of the pancreas. A review of 21 cases showed strikingly similar features. A generalized, symmetrical dermatitis initially appeared to be asteatotic or eczematous over the perineum, buttocks and lower extremities. Gradually, a more characteristic migratory necrolytic erythema with transient bulla formation and erosions developed in intertriginous and dependent areas. Histologically, the most specific features included necrolysis of the upper epidermis, with liquefaction necrosis of the granular cell layer and subcorneal clefting or blister formation. The dermatologist is often first to examine such patients. Early recognition of this syndrome with prompt surgical removal of the primary pancreatic lesion may afford cure of the neoplasm.This publication has 6 references indexed in Scilit:
- Elevated Plasma Proglucagon-like Component with a Glucagon-Secreting TumorNew England Journal of Medicine, 1976
- Hyperglucagonemia and Blood Glucose Regulation in Normal, Obese and Diabetic SubjectsNew England Journal of Medicine, 1976
- Essential Fatty Acid Deficiency in Human Adults During Total Parenteral NutritionAnnals of Internal Medicine, 1975
- Islet Cell Tumors: Current Concepts and ManagementAnnals of Internal Medicine, 1973
- Pancreatic Islet Cell CarcinomaAnnals of Internal Medicine, 1973
- Pancreatic Islet Cell CarcinomaAnnals of Internal Medicine, 1973